Aimilios Lallas,(1) Konstantinos Liopyris,(2) Zoe Apalla,(3) Elvira Moscarella,(4) Gabriella Brancaccio,(4) Alexander Stratigos,(2) Giuseppe Argenziano,(4) 1 First Department of Dermatology, School of Medicine, Faculty of Health Sciences, Aristotle University, Thessaloniki, Greece…
Andrew Dettrick, Aymaan Tayyab, Anna Kuballa, Rebecca Donkin, Duncan Lambie Abstract Background: Australia introduced structured pathology reporting guidelines for non-melanoma skin cancer (NMSC) including cutaneous squamous cell carcinoma (cSCC) in 2023 to encourage accurate histological…
Pau Rosés-Gibert, MD1,2,3,4; Cristina Heras, MD3; Narcis Ricart, PE5; et al JAMA Dermatol. Published online April 9, 2025. doi:10.1001/jamadermatol.2025.0565 Key Points Question How does an autonomous total body photographic (TBP) and dermoscopic device compare with traditional manual digital dermoscopic imaging in…
H. Peter Soyer, MD; Dilki Jayasinghe, PhD; Astrid J. Rodriguez-Acevedo, PhD; Louisa G. Collins, PhD; Liam J. Caffery, PhD; David C. Whiteman, MD, PhD; Brigid Betz-Stablein, PhD; Sonya R. Osborne, PhD; Anna Finnane, PhD; Caitlin Horsham, MSc; Clare Primiero, PhD; Leonard C. Gray, MD, PhD; Monika Janda, PhD Key Points Question Does the use of 3-dimensional (3D) total-body photography improve early…
Nina A. Ran, MD, MS; Emily E. Granger, MD; David G. Brodland, MD; et al JAMA Dermatol. Published online March 19, 2025. doi:10.1001/jamadermatol.2025.0128 Key Points Question In cutaneous squamous cell carcinoma, how is the number of risk factors associated…
Xing Fang, MD; Tianjing Gao, MD; Yu Fu, MD A woman in her 60s presented with a 4-year history of separation and rupture of the right fourth fingernail. Initially, she noted that…
Riccardo Pampena, Stefano Migliorati1, Giovanni Paolino, Michela Lai, Nicola Lippolis, Stefania Guida, Stefania Borsari, Sebastiano Pellerone, Sofia Maria Di Ciaccio, Elvira Moscarella, Giovanni Pellacani, Giuseppe Argenziano, Caterina Longo ABSTRACT Introduction:…
Serigne N. Lo, PhD; Gabrielle J. Williams, PhD; Anne E. Cust, PhD; David W. Ollila, MD; Alexander H. R. Varey, MBChB, PhD; Sydney Ch’ng, MD, PhD; Richard A. Scolyer, MD; John F. Thompson, MD Abstract Importance: Most patients…
ALLDIGITAL DERMOSCOPY & SKIN IMAGINGEVIDENCE & RESEARCHUNCATEGORISED
Having used many generations of DermLite dermatoscopes since 2004, I can confidently say that the DL5 is the undisputed champion—it’s simply impossible to beat. Integrating DermLite’s industry-leading polarization technology, the…
MoleMax Systems, a division of Macquarie Medical Systems, specialises in the development and production of dermatoscopic hardware and software, including dermatoscopes and the MoleMax Dermoscopy Software. These integrated solutions are designed for early clinical imaging sessions, analysis and comparisons of skin cancer, providing dermatologists with advanced tools for high-resolution imaging and analysis of skin lesions to improve patient outcomes.
Subscribe To The MoleMax Newsletter
